Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine

Traditional treatment failure in recurrent ovarian cancer remains a challenge for clinicians. Tumor genetic testing is a promising tool which has been proved able to identify sensitivity profiles in patients affected by cancers. This may be helpful in choosing targeted systemic treatments, aiming to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecol Oncol Rep
Hauptverfasser: Cappuccio, Serena, Distefano, Maria Grazia, Ghizzoni, Viola, Fagotti, Anna, Scambia, Giovanni
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2020
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042411/
https://ncbi.nlm.nih.gov/pubmed/32128357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2020.100547
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge